Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Haemonetics Corporation Common Stock (NY:HAE)

57.78 +0.14 (+0.24%)
Streaming Delayed Price Updated: 3:57 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Haemonetics Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Watch for Continued Gains in Shares of Haemonetics Corporation (HAE)
Via Investor Brand Network
News headline image
Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review ↗
The major indexes continued to advance, despite some key warnings. 
Via Investor's Business Daily
News headline image
Where Haemonetics Stands With Analysts ↗
  Within the last quarter, Haemonetics (NYSE:HAE) has observed the following analyst ratings: 
Via Benzinga
News headline image
Haemonetics Surges Closer To A Breakout After Squashing Quarterly Estimates, Raising Guidance ↗
The blood and plasma supplies provider also raised its sales guidance for the fiscal year. 
Via Investor's Business Daily
News headline image
Haemonetics: Q1 Earnings Insights ↗
  Haemonetics (NYSE:HAE) reported its Q1 earnings results on Wednesday, August 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Haemonetics Stock Near Buy Zone With EPS Due ↗
With its next earnings report scheduled for around Aug. 10, Haemonetics stock is trading about 10% shy of a 75.44 buy point. 
Via Investor's Business Daily
News headline image
Raymond James Thinks Haemonetics Growth Is 'Underappreciated' ↗
 
Via Benzinga
News headline image
Haemonetics: Q4 Earnings Insights ↗
Haemonetics (NYSE:HAE) reported its Q4 earnings results on Tuesday, May 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
InMode Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold ↗
On Tuesday, InMode stock got a positive adjustment to its Relative Strength (RS) Rating, to 86 from 72 a day earlier. 
Via Investor's Business Daily
News headline image
ShockWave Medical Stock Scores Rising Price Performance With Jump To 92 RS Rating ↗
ShockWave Medical stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 81 to 92. 
Via Investor's Business Daily
News headline image
Morgan Stanley Maintains Equal-Weight Rating for Haemonetics: Here's What You Need To Know ↗
Morgan Stanley has decided to maintain its Equal-Weight rating of Haemonetics (NYSE:HAE) and raise its price target from $60.00 to $70.00. Shares of Haemonetics are trading up 1.46% over the last 24... 
Via Benzinga
News headline image
4 Analysts Have This to Say About Haemonetics ↗
Over the past 3 months, 4 analysts have published their opinion on Haemonetics (NYSE:HAE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
Needham Sees Reasonable Forecasts For Haemonetics, With Some Tailwinds ↗
Haemonetics Corporation's (NYSE: HAE) analyst day later this month may include an update on its businesses, new products, margin outlook, and financial targets for FY24-FY26. 
Via Benzinga
News headline image
ShockWave Medical Stock Shows Rising Price Performance With Jump To 91 RS Rating ↗
On Monday, ShockWave Medical stock received an upgrade to its Relative Strength (RS) Rating, from 86 to 91. 
Via Investor's Business Daily
News headline image
Analyst Ratings For Haemonetics ↗
Analysts have provided the following ratings for Haemonetics (NYSE:HAE) within the last quarter: 
Via Benzinga
News headline image
Why Haemonetics Shares Are Trading Higher Today? ↗
Haemonetics Corporation (NYSE: HAE) posted  
Via Benzinga
News headline image
Recap: Haemonetics Q3 Earnings ↗
  Haemonetics (NYSE:HAE) reported its Q3 earnings results on Tuesday, February 8, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
103 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
77 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More ↗
Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ:... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Wednesday ↗
Cowen & Co. cut the price target on Chipotle Mexican Grill, Inc. (NYSE: CMG) from $2,250 to $1,950. Chipotle shares rose 6.1% to $1,549.97 in pre-market trading. 
Via Benzinga
News headline image
51 Biggest Movers From Yesterday ↗
Also check out this: Apple And 3 Other Stocks Sold By Insiders Losers SelectQuote, Inc. (NYSE: SLQT) shares tumbled 47.3% to close at $3.44 on Tuesday after the company... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Nasdaq Surges 100 Points; Graham Shares Plunge ↗
US stocks extended gains later in the session, with the Nasdaq index surging 100 points on Tuesday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers BioCardia (NASDAQ:BCDA) stock inc... 
Via Benzinga
News headline image
Mid-Day Market Update: Pfizer Sales Miss Expectations; Teradata Shares Spike Higher ↗
US stocks remained mostly higher on Tuesday, while the S&P 500 traded lower by 0.1%. 
Via Benzinga
News headline image
35 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Society Pass Incorporated (NASDAQ: SOPA) gained 63.4% to $3.45 after dropping 16% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) climbed 56.1% to $3.45 following... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big... 
Via Benzinga
News headline image
Earnings Scheduled For February 8, 2022 ↗
Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion. 
Via Benzinga
News headline image
64 Biggest Movers From Yesterday ↗
Check out these penny stocks insiders are buying Losers ION Geophysical Corporation (NYSE: IO) shares fell 53.6% to settle at $0.51 on Thursday. Epizyme, Inc. (NASDAQ:... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.